Ji Hye Kim

Ji Hye Kim

Auto-generated profile, based on publicly available information

Ji Hye Kim

Department of Pathology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2020 in Journal of Pathology and Translational Medicine
Verified
Journal Article
Open access
PDF file
JKJi Hye Kim
Ji Hye Kim
KKKyungbin Kim
Kyungbin Kim
MKMisung Kim
Misung Kim
YKYoung Min Kim
Young Min Kim
JSJae Hee Suh
Jae Hee Suh
HCHye Jeong Choi
Hye Jeong Choi
Immunomodulatory therapies targeting the interaction between programmed cell death protein 1 and programmed death-ligand 1 (PD-L1) have become increasingly important in anticancer treatment. Previous research on the subject of this immune response has established an association with tumor aggressiveness and a poor prognosis in certain cancers. Currently, scant information is available on the relationship between PD-L1 expression and gallbladder cancer (GBC). We investigated the expression of PD-L1 in 101 primary GBC cases to determine the potential association with prognostic impact. PD-L1 expression was immunohistochemically assessed using a single PD-L1 antibody (clone SP263). Correlations with clinicopathological parameters, overall survival (OS), or progression- free survival (PFS) were analyzed. PD-L1 expression in tumor cells at cutoff levels of 1%, 10%, and 50% was present in 18.8%, 13.8%, and 7.9% of cases. Our study showed that positive PD-L1 expression at any cutoff was significantly correlated with poorly differentiated histologic grade and the presence of lymphovascular invasion (p < .05). PD-L1 expression at cutoff levels of 10% and 50% was significantly positive in patients with perineural invasion, higher T categories, and higher pathologic stages (p < .05). Additionally, there was a significant association noted between PD-L1 expression at a cutoff level of 50% and worse OS or PFS (p = .049 for OS, p = .028 for PFS). Other poor prognostic factors included histologic grade, T category, N category, pathologic stage, lymphovascular invasion, perineural invasion, growth pattern, and margin of resection (p < .05). The expression of PD-L1 in GBC varies according to cutoff level but is valuably associated with poor prognostic parameters and survival. Our study indicates that the overexpression of PD-L1 in GBC had a negative prognostic impact.

15 July 2020 in Journal of Pathology and Translational Medicine
Verified
Journal Article
Open access
PDF file
SCSoyeon Choi
Soyeon Choi
JKJi Hye Kim
Ji Hye Kim
KKKyungbin Kim
Kyungbin Kim
MKMisung Kim
Misung Kim
HCHye Jeong Choi
Hye Jeong Choi
HCHee Jeong Cha
Hee Jeong Cha
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma), is one of the specific type of low-grade B-cell lymphoma not infrequently found worldwide. It typically involves mucosal sites such as stomach and conjunctiva; however, primary hepatic MALT lymphoma has been extremely rarely reported. We describe a case of hepatic MALT lymphoma in a 70-year-old male patient who underwent left hepatectomy due to the incidentally detected liver masses at a medical checkup. The resected specimen revealed multinodular masses consisting of small-to-intermediate-sized lymphoid cells with serpentine pattern and focal lymphoepithelial lesions. The tumor cells were diffusely positive for CD20 and Bcl-2 but negative for CD3, CD10, CD5, CD23, CD43, and cyclinD1. The Ki-67 labeling index was 10% and immunoglobulin heavy chain gene rearrangement study confirmed monoclonal proliferation. In this paper, we discuss several unique clinicopathologic characteristics which will be helpful to the differential diagnosis of hepatic MALT lymphoma.

1 January 2025 in Investigative and Clinical Urology
Verified
Journal Article
Open access
PDF file
JLJeong Min Lee
Jeong Min Lee
WLWon Hyeok Lee
Won Hyeok Lee
SCSeung Hyeon Cho
Seung Hyeon Cho
JPJeong Woo Park
Jeong Woo Park
HKHYUK NAM KWON
HYUK NAM KWON
SKSeong Cheol Kim
Seong Cheol Kim
Lee JM, et al. Investig Clin Urol. 2025 Jan;66(1):56-66. https://doi.org/10.4111/icu.20240263

15 November 2025 in Journal of Pathology and Translational Medicine
Verified
Journal Article
Open access
HJHye-Ra Jung
Hye-Ra Jung
JSJunyoung Shin
Junyoung Shin
CYChong Woo Yoo
Chong Woo Yoo
EKEun Na Kim
Eun Na Kim
CLCheol Lee
Cheol Lee
HKHyun Jung Kim
Hyun Jung Kim
Background: Human papillomavirus (HPV) independent cervical malignancies (HPV-IDCMs) have recently been classified by the World Health Organization (WHO) 5th edition. These malignancies have historically received limited attention due to their rarity and the potential for evasion of HPV-based screening.Methods: We retrospectively reviewed 5,854 biopsy-confirmed cervical malignancies from 22 institutions over 3 years (July 2020–June 2023). Histologic classification followed the WHO guidelines. HPV independence was confirmed by dual negativity for p16 and HPV; discordant cases (p16-positive/HPV-negative) underwent additional HPV testing using paraffin-embedded tissue. Cytological results were matched sequentially to histological confirmation.Results: The prevalence of HPV-IDCM was 4.4% (257/5,854) overall and was 3.6% (208/5,805 cases) among primary cervical malignancy. Patient age of HPV-IDCM was 29 to 89 years (median, 57.79). Its histologic subtypes included primary adenocarcinoma (n = 116), endometrial adenocarcinoma (n = 35), squamous cell carcinoma (n = 72), metastatic carcinoma (n = 14), carcinoma, not otherwise specified (n = 10), neuroendocrine carcinoma (n = 3), and others (n = 7). Among 155 cytology-histological matched cases, the overall and primary Pap test detection rates were 85.2% (132/155) and 83.2% (104/125), respectively. The interval between cytology and histologic confirmation extended up to 38 months.Conclusions: HPV-IDCMs comprised 3.6% of primary cervical malignancies with a high detection rate via cytology (83.2%). These findings affirm the value of cytological screening, particularly in patients with limited screening history or at risk for HPV-independent lesions, and may guide future screening protocols.

1 January 2026 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
WLWon Hyeok Lee
Won Hyeok Lee
SKSeong Cheol Kim
Seong Cheol Kim
JYJi Hyung Yoon
Ji Hyung Yoon
SCSeung Hyeon Cho
Seung Hyeon Cho
KMKyung Hyun Moon
Kyung Hyun Moon
SPSungchan Park
Sungchan Park
Lee WH, et al. World J Mens Health. 2026 ;44:e85. https://doi.org/10.5534/wjmh.260048

28 March 2026 in Neurology and Therapy
Verified
Journal Article
Open access
PDF file
ELEunmi Lee
Eunmi Lee
HLHyunjo Lee
Hyunjo Lee
JKJi Hye Kim
Ji Hye Kim
Isolated neurosarcoidosis (INS) is a rare inflammatory disorder of the central nervous system that lacks systemic manifestations and mimics neoplastic or infectious conditions, making diagnosis challenging. We report a case of a previously healthy 30-year-old man who presented with recurrent transient loss of consciousness and progressive right leg weakness. Brain magnetic resonance imaging (MRI) demonstrated multiple uniformly contrast-enhancing nodular lesions involving the pachymeninges and cranial nerves, while spinal MRI revealed conus medullaris enhancement with associated lumbosacral nerve root thickening. Stereotactic biopsy of an MRI-enhancing pachymeningeal lesion demonstrated chronic granulomatous inflammation, with infectious and neoplastic etiologies excluded, leading to a diagnosis of INS. Subsequent 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) revealed marked metabolic heterogeneity, with mixed hyper- and hypometabolic cerebral nodules and metabolically inactive pachymeningeal and spinal lesions. This case illustrates spatiotemporal inflammatory heterogeneity in INS and highlights multimodal imaging findings demonstrating structural-metabolic discordance. Early incorporation of PET/CT alongside MRI may provide complementary metabolic information that assists lesion characterization in diagnostically complex central nervous system inflammatory diseases.